🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

Walgreens Shares Continue to Decline Amid Unfavorable Market Conditions

EditorVenkatesh Jartarkar
Published 20/10/2023, 10:18
© Pavlo Gonchar / SOPA Images/Sipa via Reuters Connect
US500
-
DJI
-
WBA
-

Walgreens Boots Alliance (NASDAQ:WBA) Inc. continued its downward trend on Thursday, with its share price falling to $20.96, a sizeable drop from its previous 52-week high of $42.29. This decline mirrors the unfavorable market conditions impacting the broader market, as well as the company's specific challenges.

The S&P 500 and Dow Jones also experienced declines on Thursday, falling by 0.85% and 0.75% respectively. Walgreens' performance was notably weaker than its competitors in the market, a trend that has been consistent in recent months.

In comparison, Amazon.com Inc (NASDAQ:AMZN). saw its shares rise by 0.21%, while CVS Health Corp (NYSE:CVS).'s shares increased by 0.18%. McKesson Corp (NYSE:MCK)., another competitor, also experienced a decline, but it was less severe than that of Walgreens, with a drop of only 0.54%.

Walgreens' trading volume stood at 10.8 million on Thursday, significantly below its typical 50-day average volume, which according to InvestingPro Data, is typically around 11.77 million. This suggests that investors might be exercising caution in the face of the current market volatility.

InvestingPro Data shows that Walgreens has a market cap of 18.11B USD and a negative P/E Ratio of -5.95. The company's revenue for the last twelve months (LTM2023.Q4) stood at 139.08B USD, marking a growth of 4.81%. Despite the increasing revenue, the company's EBITDA growth for the same period was -23.0 %, indicating a decline in earnings before interest, taxes, depreciation, and amortization.

InvestingPro Tips reveals that Walgreens has a history of rewarding its shareholders. The company has raised its dividend for 47 consecutive years and pays a significant dividend to its shareholders. The dividend yield as of Y2023.D293 was 9.16%, a testament to the company's commitment to its shareholders.

The same source also indicates that the company has been facing some challenges. The stock has taken a significant hit over the last week, month, and three months, with a 1-week price total return of -9.85%, 1-month return of -4.03%, and a 3-month return of -29.44%. The company's stock is also trading near its 52-week low.

In these turbulent times, Walgreens' recent performance presents a stark contrast to its previous highs, indicating the impact of broader market trends on individual companies. As always, investors will be closely watching the market for signs of recovery or further declines. For those interested in more information like this, InvestingPro offers additional tips and real-time metrics to help make informed investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.